Madrigal shares skyrocket on positive NASH treatment study results
December 19, 2022 at 09:36 AM EST
The Conshohocken company expects to seek approval for its treatment of an inflammatory liver disease during the first half of 2023.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
